Related Experiment Video
Updated: Aug 2, 2026

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain
1Department of Medicine, University of Washington, Puget Sound Blood Center, Seattle 98104-1256, USA.
Insights
Mutations in factor VIII C domains affect binding to von Willebrand factor (vWF), potentially causing hemophilia by reducing factor VIII stability. Some mutations also correlate with inhibitor development in hemophilia A patients.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Factor VIII C domains are crucial for binding von Willebrand factor (vWF) and phospholipid membranes.
- Hemophilia A is a bleeding disorder often caused by mutations in the Factor VIII gene.
Purpose of the Study:
- To identify and characterize mutations within the Factor VIII C domains.
- To investigate the impact of these mutations on vWF binding and their association with hemophilia A and inhibitor development.
Main Methods:
- Screening of hemophilic patients for Factor VIII C-domain mutations.
- Localization of mutated residues to high-resolution C2 structure and homology models of C1.
- Analysis of mutation effects on vWF binding, Factor VIII clotting activity, and antigen levels.
- Combination of new data with an international mutation database.
Main Results:
- 14 missense mutations were identified in 30 families, with 9 being novel.
- 10 missense mutations showed reduced vWF binding, with 8 at surface-exposed residues.
- Six of these mutants had near-normal Factor VIII clotting activity and antigen levels, suggesting reduced vWF binding impacts stability.
- 11 C1 and C2 mutations were associated with antibody-inhibitor development in hemophilia A patients, with 6 at surface-exposed residues.
Conclusions:
- Reduced vWF binding due to C-domain mutations may cause hemophilia by decreasing Factor VIII stability.
- Specific Factor VIII C-domain mutations are linked to antibody-inhibitor development in hemophilia A.
- Further structural and binding studies will improve prediction of surface binding sites and their clinical relevance.
Abstract:
Factor VIII C domains contain key binding sites for von Willebrand factor (vWF) and phospholipid membranes. Hemophilic patients were screened for factor VIII C-domain mutations to provide a well-characterized series. Mutated residues were localized to the high-resolution C2 structure and to a homology model of C1. Of 30 families found with mutations in the C domains, there were 14 missense changes, and 9 of these were novel. Of the missense mutations, 10 were associated with reduced vWF binding and 8 were at residues with surface-exposed side chains. Six of the 10 mutants had nearly equivalent factor VIII clotting activity and antigen level, suggesting that reduced vWF binding could cause hemophilia by reducing factor VIII stability in circulation. When the present series was combined with previously described mutations from an online international database, 11 C1 and C2 mutations in patients with mild or moderately severe hemophilia A were associated with antibody-inhibitor development in at least one affected individual. Of these substitutions, 6 occurred at surface-exposed residues. As further details of the C1 structure and its interface with C2 become available, and as binding studies are performed on the plasma of more patients with hemophilic C-domain mutations, prediction of surface binding sites should improve, allowing confirmation by site-specific mutagenesis of surface-exposed residues.
Related Concept Videos
Molecular Models
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Globular and Fibrous Proteins
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...

